|
1
|
Gratwohl A, Baldomero H and Passweg J:
Hematopoietic stem cell transplantation activity in Europe. Curr
Opin Hematol. 20:485–493. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Blazar BR, Murphy WJ and Abedi M: Advances
in graft-versus-host disease biology and therapy. Nat Rev Immunol.
12:443–458. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Socié G and Blazar BR: Acute
graft-versus-host disease: From the bench to the bedside. Blood.
114:4327–4336. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wysocki CA, Panoskaltsis-Mortari A, Blazar
BR and Serody JS: Leukocyte migration and graft-versus-host
disease. Blood. 105:4191–4199. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Anderson BE, Zheng H, Taylor PA,
Matte-Martone C, McNiff JM, Jain D, Demetris AJ,
Panoskaltsis-Mortari A, Ager A, Blazar BR, et al: Memory T cells in
GVHD and GVL. Biol Blood Marrow Transplant. 14(1 Suppl 1): S19–S20.
2008.
|
|
6
|
Shlomchik WD, Couzens MS, Tang CB, McNiff
J, Robert ME, Liu J, Shlomchik MJ and Emerson SG: Prevention of
graft versus host disease by inactivation of host
antigen-presenting cells. Science. 285:412–415. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Pira G, Di Cecca S, Montanari M,
Moretta L and Manca F: Specific removal of alloreactive T-cells to
prevent GvHD in hemopoietic stem cell transplantation: Rationale,
strategies and perspectives. Blood Rev. 30:297–307. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Spoerl S, Mathew NR, Bscheider M,
Schmitt-Graeff A, Chen S, Mueller T, Verbeek M, Fischer J, Otten V,
Schmickl M, et al: Activity of therapeutic JAK 1/2 blockade in
graft-versus-host disease. Blood. 123:3832–3842. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu SX, Alpdogan O, Lin J, Balderas R,
Campos-Gonzalez R, Wang X, Gao GJ, Suh D, King C, Chow M, et al:
STAT-3 and ERK 1/2 phosphorylation are critical for T-cell
alloactivation and graft-versus-host disease. Blood. 112:5254–5258.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fujino M and Li XK: Role of STAT3 in
regulatory T lymphocyte plasticity during acute
graft-vs.-host-disease. JAKSTAT. 2:e245292013.PubMed/NCBI
|
|
11
|
Radojcic V, Pletneva MA, Yen HR, Ivcevic
S, Panoskaltsis-Mortari A, Gilliam AC, Drake CG, Blazar BR and
Luznik L: STAT3 signaling in CD4+ T cells is critical
for the pathogenesis of chronic sclerodermatous graft-versus-host
disease in a murine model. J Immunol. 184:764–774. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma HH, Ziegler J, Li C, Sepulveda A,
Bedeir A, Grandis J, Lentzsch S and Mapara MY: Sequential
activation of inflammatory signaling pathways during
graft-versus-host disease (GVHD): Early role for STAT1 and STAT3.
Cell Immunol. 268:37–46. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Laurence A, Amarnath S, Mariotti J, Kim
YC, Foley J, Eckhaus M, O'Shea JJ and Fowler DH: STAT3
transcription factor promotes instability of nTreg cells and limits
generation of iTreg cells during acute murine graft-versus-host
disease. Immunity. 37:209–222. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hill GR, Kuns RD, Raffelt NC, Don AL,
Olver SD, Markey KA, Wilson YA, Tocker J, Alexander WS, Clouston
AD, et al: SOCS3 regulates graft-versus-host disease. Blood.
116:287–296. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen X, Das R, Komorowski R, Beres A,
Hessner MJ, Mihara M and Drobyski WR: Blockade of interleukin-6
signaling augments regulatory T-cell reconstitution and attenuates
the severity of graft-versus-host disease. Blood. 114:891–900.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee SH, Moon SJ, Park MJ, Kim EK, Moon YM
and Cho ML: PIAS3 suppresses acute graft-versus-host disease by
modulating effector T and B cell subsets through inhibition of
STAT3 activation. Immunol Lett. 160:79–88. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Carniti C, Gimondi S, Vendramin A,
Recordati C, Confalonieri D, Bermema A, Corradini P and Mariotti J:
Pharmacologic inhibition of JAK1/JAK2 signaling reduces
experimental murine acute GVHD while preserving GVT effects. Clin
Cancer Res. 21:3740–3749. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jaekel N, Behre G, Behning A, Wickenhauser
C, Lange T, Niederwieser D and Al-Ali HK: Allogeneic hematopoietic
cell transplantation for myelofibrosis in patients pretreated with
the JAK1 and JAK2 inhibitor ruxolitinib. Bone Marrow Transplant.
49:179–184. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park HB, Oh K, Garmaa N, Seo MW, Byoun OJ,
Lee HY and Lee DS: CP-690550, a Janus kinase inhibitor, suppresses
CD4+ T-cell-mediated acute graft-versus-host disease by
inhibiting the interferon-γ pathway. Transplantation. 90:825–835.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Betts BC, Abdel-Wahab O, Curran SA, St
Angelo ET, Koppikar P, Heller G, Levine RL and Young JW: Janus
kinase-2 inhibition induces durable tolerance to alloantigen by
human dendritic cell-stimulated T cells yet preserves immunity to
recall antigen. Blood. 118:5330–5339. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tawara I, Koyama M, Liu C, Toubai T,
Thomas D, Evers R, Chockley P, Nieves E, Sun Y, Lowler KP, et al:
Interleukin-6 modulates graft-versus-host responses after
experimental allogeneic bone marrow transplantation. Clin Cancer
Res. 17:77–88. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nelson EA, Walker SR, Kepich A, Gashin LB,
Hideshima T, Ikeda H, Chauhan D, Anderson KC and Frank DA:
Nifuroxazide inhibits survival of multiple myeloma cells by
directly inhibiting STAT3. Blood. 112:5095–5102. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cooke KR, Kobzik L, Martin TR, et al: An
experimental model of idiopathic pneumonia syndrome after bone
marrow transplantation: I. The roles of minor H antigens and
endotoxin. Blood. 88:3230–3239. 1996.PubMed/NCBI
|
|
24
|
Kim SS: Treatment options in
steroid-refractory acute graft-versus-host disease following
hematopoietic stem cell transplantation. Ann Pharmacother.
41:1436–1444. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Beilhack A, Schulz S, Baker J, Beilhack
GF, Wieland CB, Herman EI, Baker EM, Cao YA, Contag CH and Negrin
RS: In vivo analyses of early events in acute graft-versus-host
disease reveal sequential infiltration of T-cell subsets. Blood.
106:1113–1122. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dijke IE, Hoeppli RE, Ellis T, Pearcey J,
Huang Q, McMurchy AN, Boer K, Peeters AM, Aubert G, Larsen I, et
al: Discarded human thymus is a novel source of stable and
long-lived therapeutic regulatory T Cells. Am J Transplant.
16:58–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fujii N, Hiraki A, Aoe K, Murakami T,
Ikeda K, Masuda K, Matsuo K, Shinagawa K, Ishimaru F, Sugi K, et
al: Serum cytokine concentrations and acute graft-versus-host
disease after allogeneic peripheral blood stem cell
transplantation: Concurrent measurement of ten cytokines and their
respective ratios using cytometric bead array. Int J Mol Med.
17:881–885. 2006.PubMed/NCBI
|
|
28
|
Ju XP, Xu B, Xiao ZP, Li JY, Chen L, Lu SQ
and Huang ZX: Cytokine expression during acute graft-versus-host
disease after allogeneic peripheral stem cell transplantation. Bone
Marrow Transplant. 35:1179–1186. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cipolla BG, Havouis R and Moulinoux JP:
Polyamine contents in current foods: A basis for polyamine reduced
diet and a study of its long term observance and tolerance in
prostate carcinoma patients. Amino Acids. 33:203–212. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cipolla BG, Havouis R and Moulinoux JP:
Polyamine reduced diet (PRD) nutrition therapy in hormone
refractory prostate cancer patients. Biomed Pharmacother.
64:363–368. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qiao S, Ren H, Shi Y and Liu W: Allogeneic
compact bone-derived mesenchymal stem cell transplantation
increases survival of mice exposed to lethal total body
irradiation: A potential immunological mechanism. Chin Med J
(Engl). 127:475–482. 2014.PubMed/NCBI
|
|
32
|
Joly F, Breton M, Wolf C, Ninio E and
Colard O: Heterogeneity of arachidonate and paf-acether precursor
pools in mast cells. Biochim Biophys Acta. 1125:305–312. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Panoskaltsis-Mortari A, Price A, Hermanson
JR, Taras E, Lees C, Serody JS and Blazar BR: In vivo imaging of
graft-versus-host-disease in mice. Blood. 103:3590–3598. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Burman AC, Banovic T, Kuns RD, Clouston
AD, Stanley AC, Morris ES, Rowe V, Bofinger H, Skoczylas R, Raffelt
N, et al: IFNgamma differentially controls the development of
idiopathic pneumonia syndrome and GVHD of the gastrointestinal
tract. Blood. 110:1064–1072. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Delisle JS, Gaboury L, Bélanger MP, Tassé
E, Yagita H and Perreault C: Graft-versus-host disease causes
failure of donor hematopoiesis and lymphopoiesis in
interferon-gamma receptor-deficient hosts. Blood. 112:2111–2119.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yi T, Chen Y, Wang L, Du G, Huang D, Zhao
D, Johnston H, Young J, Todorov I, Umetsu DT, et al: Reciprocal
differentiation and tissue-specific pathogenesis of Th1, Th2, and
Th17 cells in graft-versus-host disease. Blood. 114:3101–3112.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Couriel D, Saliba R, Hicks K, Ippoliti C,
de Lima M, Hosing C, Khouri I, Andersson B, Gajewski J, Donato M,
et al: Tumor necrosis factor-alpha blockade for the treatment of
acute GVHD. Blood. 104:649–654. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu Y, Ye T, Yu X, Lei Q, Yang F, Xia Y,
Song X, Liu L, Deng H, Gao T, et al: Nifuroxazide exerts potent
anti-tumor and anti-metastasis activity in melanoma. Sci Rep.
6:202532016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang F, Hu M, Lei Q, Xia Y, Zhu Y, Song X,
Li Y, Jie H, Liu C, Xiong Y, et al: Nifuroxazide induces apoptosis
and impairs pulmonary metastasis in breast cancer model. Cell Death
Dis. 6:e17012015. View Article : Google Scholar : PubMed/NCBI
|
